In short, we came to the speculation that CRC patients may have a reduced likelihood of developing KRAS mutation in the presence of some gut microbiota such as Bifidobacterium and Akkermansia, which, to some extent, hinder the progression of CRC. Here, KRAS is linked to colorectal carcinoma.